A strategy to determine HLA class II restriction broadly covering the DR, DP, and DQ allelic variants most commonly expressed in the general population

Immunogenetics

Volumn 65, Issue 5, 2013, Pages 357-370

  McKinney, Denise M ^a   Southwood, Scott ^a   Hinz, Denise ^a   Oseroff, Carla ^a   Arlehamn, Cecilia S Lindestam ^a   Schulten, Veronique ^a   Taplitz, Randy ^b   Broide, David ^b   Hanekom, Willem A ^c   Scriba, Thomas J ^c   Wood, Robert ^d   Alam, Rafeul ^e   Peters, Bjoern ^a   Sidney, John ^a   Sette, Alessandro ^a  

^a LA JOLLA INSTITUTE FOR ALLERGY AND IMMUNOLOGY   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF CAPE TOWN   (South Africa)

^d JOHNS HOPKINS UNIVERSITY   (United States)

^e DEPARTMENT OF MEDICINE   (United States)

Author keywords

Epitopes; HLA Class II; Polymorphism; Population coverage; Restriction; Transfectants

Indexed keywords

HLA ANTIGEN CLASS 2; HLA DP ANTIGEN; HLA DQ ANTIGEN; HLA DR ANTIGEN; EPITOPE; PEPTIDE FRAGMENT;

ALLELE; ANTIGEN BINDING; ARTICLE; CONTROLLED STUDY; ETHNICITY; FLUORESCENCE ACTIVATED CELL SORTING; GENE EXPRESSION; HLA SYSTEM; HLA TYPING; HUMAN; HUMAN CELL; MAJOR HISTOCOMPATIBILITY COMPLEX RESTRICTION; PHENOTYPE; POPULATION RESEARCH; PRIORITY JOURNAL; SOUTH AFRICA; UNITED STATES; VALIDATION STUDY; ANTIGEN PRESENTATION; B LYMPHOCYTE; CELL CULTURE; GENETIC VARIABILITY; GENETICS; IMMUNOLOGY; POPULATION GENETICS; T LYMPHOCYTE;

ALLELES; ANTIGEN PRESENTATION; B-LYMPHOCYTES; CELLS, CULTURED; EPITOPES; GENETIC VARIATION; GENETICS, POPULATION; HISTOCOMPATIBILITY ANTIGENS CLASS II; HLA-DP ANTIGENS; HLA-DQ ANTIGENS; HLA-DR ANTIGENS; HUMANS; PEPTIDE FRAGMENTS; T-LYMPHOCYTES;

MLCS; MLOWN;

EID: 84879023453     PISSN: 00937711     EISSN: 14321211     Source Type: Journal    
DOI: 10.1007/s00251-013-0684-y     Document Type: Article

References (66)

1. Alcaide-Loridan C, Lennon AM, Bono MR, Barbouche R, Dellagi K, Fellous M (1999) Differential expression of MHC class II isotype chains. Microbes Infect/Inst Pasteur 1(11):929-934
2. Alivisatos AP, Gu W, Larabell C (2005) Quantum dots as cellular probes. Annu Rev Biomed Eng 7:55-76. doi: 10.1146/annurev.bioeng.7.060804.100432
3. Arlehamn CS, Gerasimova A, Mele F, Henderson R, Swann J, Greenbaum JA, Kim Y, Sidney J, James EA, Taplitz R, McKinney DM, Kwok WW, Grey H, Sallusto F, Peters B, Sette A (2013) Memory T cells in latent Mycobacterium tuberculosis infection are directed against three antigenic islands and largely contained in a CXCR3+CCR6+ Th1 subset. PLoS Pathog 9(1):e1003130. doi: 10.1371/journal.ppat. 1003130
4. Arlehamn CS, Sidney J, Henderson R, Greenbaum JA, James EA, Moutaftsi M, Coler R, McKinney DM, Park D, Taplitz R, Kwok WW, Grey H, Peters B, Sette A (2012b) Dissecting mechanisms of immunodominance to the common tuberculosis antigens ESAT-6, CFP10, Rv2031c (hspX), Rv2654c (TB7.7), and Rv1038c (EsxJ). J Immunol 188(10):5020-5031. doi: 10.4049/jimmunol.1103556
5. Austin P, Trowsdale J, Rudd C, Bodmer W, Feldmann M, Lamb J (1985) Functional expression of HLA-DP genes transfected into mouse fibroblasts. Nature 313(5997):61-64
6. Busch R, Strang G, Howland K, Rothbard JB (1990) Degenerate binding of immunogenic peptides to HLA-DR proteins on B cell surfaces. Int Immunol 2(5):443-451
7. Calman AF, Peterlin BM (1988) Evidence for a trans-acting factor that regulates the transcription of class II major histocompatibility complex genes: genetic and functional analysis. Proc Natl Acad Sci U S A 85(23):8830-8834
8. Cheng Y, Prusoff WH (1973) Relationship between the inhibition constant (K1) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reaction. Biochem Pharmacol 22(23):3099-3108
9. Constantin CM, Bonney EE, Altman JD, Strickland OL (2002) Major histocompatibility complex (MHC) tetramer technology: an evaluation. Biol Res Nurs 4(2):115-127
10. Doherty DG, Penzotti JE, Koelle DM, Kwok WW, Lybrand TP, Masewicz S, Nepom GT (1998) Structural basis of specificity and degeneracy of T cell recognition: pluriallelic restriction of T cell responses to a peptide antigen involves both specific and promiscuous interactions between the T cell receptor, peptide, and HLA-DR. J Immunol 161(7):3527-3535
11. Dzuris JL, Sidney J, Horton H, Correa R, Carter D, Chesnut RW, Watkins DI, Sette A (2001) Molecular determinants of peptide binding to two common rhesus macaque major histocompatibility complex class II molecules. J Virol 75(22):10958-10968
12. Edwards JA, Durant BM, Jones DB, Evans PR, Smith JL (1986) Differential expression of HLA class II antigens in fetal human spleen: relationship of HLA-DP, DQ, and DR to immunoglobulin expression. J Immunol 137(2):490-497
13. Giraldo-Vela JP, Rudersdorf R, Chung C, Qi Y, Wallace LT, Bimber B, Borchardt GJ, Fisk DL, Glidden CE, Loffredo JT, Piaskowski SM, Furlott JR, Morales-Martinez JP, Wilson NA, Rehrauer WM, Lifson JD, Carrington M, Watkins DI (2008) The major histocompatibility complex class II alleles Mamu-DRB11003 and -DRB10306 are enriched in a cohort of simian immunodeficiency virus-infected rhesus macaque elite controllers. J Virol 82(2):859-870. doi: 10.1128/JVI.01816-07
14. Greenbaum J, Sidney J, Chung J, Brander C, Peters B, Sette A (2011) Functional classification of class II human leukocyte antigen (HLA) molecules reveals seven different supertypes and a surprising degree of repertoire sharing across supertypes. Immunogenetics 63(6):325-335. doi: 10.1007/s00251-011-0513-0
15. Guardiola J, Maffei A (1993) Control of MHC class II gene expression in autoimmune, infectious, and neoplastic diseases. Crit Rev Immunol 13(3-4):247-268
16. Gulukota K, Sidney J, Sette A, DeLisi C (1997) Two complementary methods for predicting peptides binding major histocompatibility complex molecules. J Mol Biol 267(5):1258-1267
17. Hauber I, Gulle H, Wolf HM, Maris M, Eggenbauer H, Eibl MM (1995) Molecular characterization of major histocompatibility complex class II gene expression and demonstration of antigen-specific T cell response indicate a new phenotype in class II-deficient patients. J Exp Med 181(4):1411-1423
18. Ho PC, Mutch DA, Winkel KD, Saul AJ, Jones GL, Doran TJ, Rzepczyk CM (1990) Identification of two promiscuous T cell epitopes from tetanus toxin. Eur J Immunol 20(3):477-483. doi: 10.1002/eji.1830200304
19. Jacobson S, Sekaly RP, Jacobson CL, McFarland HF, Long EO (1989) HLA class II-restricted presentation of cytoplasmic measles virus antigens to cytotoxic T cells. J Virol 63(4):1756-1762
20. James EA, Bui J, Berger D, Huston L, Roti M, Kwok WW (2007) Tetramer-guided epitope mapping reveals broad, individualized repertoires of tetanus toxin-specific CD4+ T cells and suggests HLA-based differences in epitope recognition. Int Immunol 19(11):1291-1301. doi: 10.1093/intimm/dxm099
21. Jaraquemada D, Martin R, Rosen-Bronson S, Flerlage M, McFarland HF, Long EO (1990) HLA-DR2a is the dominant restriction molecule for the cytotoxic T cell response to myelin basic protein in DR2Dw2 individuals. J Immunol 145(9):2880-2885
22. Karr RW, Panina-Bordignon P, Yu WY, Lanzavecchia A (1991) Antigen-specific T cells with monogamous or promiscuous restriction patterns are sensitive to different HLA-DR beta chain substitutions. J Immunol 146(12):4242-4247
23. Klohe EP, Watts R, Bahl M, Alber C, Yu WY, Anderson R, Silver J, Gregersen PK, Karr RW (1988) Analysis of the molecular specificities of anti-class II monoclonal antibodies by using L cell transfectants expressing HLA class II molecules. J Immunol 141(6):2158-2164
24. Kotturi MF, Scott I, Wolfe T, Peters B, Sidney J, Cheroutre H, von Herrath MG, Buchmeier MJ, Grey H, Sette A (2008) Naive precursor frequencies and MHC binding rather than the degree of epitope diversity shape CD8+ T cell immunodominance. J Immunol 181(3):2124-2133. doi: 181/3/2124
25. Krieger JI, Karr RW, Grey HM, Yu WY, O'Sullivan D, Batovsky L, Zheng ZL, Colon SM, Gaeta FC, Sidney J et al (1991) Single amino acid changes in DR and antigen define residues critical for peptide-MHC binding and T cell recognition. J Immunol 146(7):2331-2340
26. Kwok WW (2003) Challenges in staining T cells using HLA class II tetramers. Clin Immunol 106(1):23-28
27. Lair B, Alber C, Yu WY, Watts R, Bahl M, Karr RW (1988) A newly characterized HLA-DP beta-chain allele. Evidence for DP beta heterogeneity within the DPw4 specificity. J Immunol 141(4):1353-1357
28. Larche M (2008) Determining MHC restriction of T-cell responses. Methods Mol Med 138:57-72. doi: 10.1007/978-1-59745-366-0-6
29. Lechler RI, Bal V, Rothbard JB, Germain RN, Sekaly R, Long EO, Lamb J (1988) Structural and functional studies of HLA-DR restricted antigen recognition by human helper T lymphocyte clones by using transfected murine cell lines. J Immunol 141(9):3003-3009
30. Marsh SGE, Parham P, Barber LD (2000) The HLA FactsBook. Academic Press, London
31. Maurer DH, Hanke JH, Mickelson E, Rich RR, Pollack MS (1987) Differential presentation of HLA-DR, DQ, and DP restriction elements by interferon-gamma- treated dermal fibroblasts. J Immunol 139(3):715-723
32. Meyer D, Singe R, Mack S, Lancaster A, Nelson M, Erlich H, Frenandez-Vina M, Thomson G (2007) Single Locus Polymorphism of Classical HLA Genes. Immunobiology of the Human MHC: Proceedings of the 13th International Histocompatibility Workshop and Conference; Seattle, WA:653-704
33. Middleton D, Menchaca L, Rood H, Komerofsky R (2003) New allele frequency database. Tissue Antigens 61(5):403-407, http://www.allelefrequencies.net
34. Moon JJ, Chu HH, Pepper M, McSorley SJ, Jameson SC, Kedl RM, Jenkins MK (2007) Naive CD4(+) T cell frequency varies for different epitopes and predicts repertoire diversity and response magnitude. Immunity 27(2):203-213. doi: 10.1016/j.immuni.2007.07.007
35. Moon JJ, Chu HH, Hataye J, Pagan AJ, Pepper M, McLachlan JB, Zell T, Jenkins MK (2009) Tracking epitope-specific T cells. Nat Protoc 4(4):565-581. doi: 10.1038/nprot.2009.9
36. Nakatsuji T, Inoko H, Ando A, Sato T, Koide Y, Tadakuma T, Yoshida TO, Tsuji K (1987) The role of transfected HLA-DQ genes in the mixed lymphocyte reaction-like condition. Immunogenetics 25(1):1-6
37. Nepom GT (2012) MHC class II tetramers. J Immunol 188(6):2477-2482. doi: 10.4049/jimmunol.1102398
38. Nepom GT, Buckner JH, Novak EJ, Reichstetter S, Reijonen H, Gebe J, Wang R, Swanson E, Kwok WW (2002) HLA class II tetramers: tools for direct analysis of antigen-specific CD4+ T cells. Arthritis Rheum 46(1):5-12. doi:10.1002/1529-0131(200201)46:1<5::AID-ART10063>3.0.CO;2-S
39. Newell EW, Sigal N, Bendall SC, Nolan GP, Davis MM (2012) Cytometry by time-of-flight shows combinatorial cytokine expression and virus-specific cell niches within a continuum of CD8+ T cell phenotypes. Immunity 36(1):142-152. doi: 10.1016/j.immuni.2012.01.002
40. Oseroff C, Sidney J, Kotturi MF, Kolla R, Alam R, Broide DH, Wasserman SI, Weiskopf D, McKinney DM, Chung JL, Petersen A, Grey H, Peters B, Sette A (2010) Molecular determinants of T cell epitope recognition to the common Timothy grass allergen. J Immunol 185(2):943-955. doi: 10.4049/jimmunol.1000405
41. Oseroff C, Sidney J, Tripple V, Grey H, Wood R, Broide DH, Greenbaum J, Kolla R, Peters B, Pomes A, Sette A (2012a) Analysis of T Cell responses to the major allergens from German cockroach: epitope specificity and relationship to IgE production. J Immunol 189(2):679-688. doi: 10.4049/jimmunol.1200694
42. Oseroff C, Sidney J, Vita R, Tripple V, McKinney DM, Southwood S, Brodie TM, Sallusto F, Grey H, Alam R, Broide D, Greenbaum JA, Kolla R, Peters B, Sette A (2012b) T Cell Responses to known allergen proteins are differently polarized and account for a variable fraction of total response to allergen extracts. J Immunol. doi: 10.4049/jimmunol.1200850
43. O'Sullivan D, Sidney J, Appella E, Walker L, Phillips L, Colon SM, Miles C, Chesnut RW, Sette A (1990) Characterization of the specificity of peptide binding to four DR haplotypes. J Immunol 145(6):1799-1808
44. O'Sullivan D, Arrhenius T, Sidney J, Del Guercio MF, Albertson M, Wall M, Oseroff C, Southwood S, Colon SM, Gaeta FC et al (1991) On the interaction of promiscuous antigenic peptides with different DR alleles. Identification of common structural motifs. J Immunol 147(8):2663-2669
45. Panina-Bordignon P, Demotz S, Corradin G, Lanzavecchia A (1989a) Study on the immunogenicity of human class-II-restricted T-cell epitopes: processing constraints, degenerate binding, and promiscuous recognition. Cold Spring Harb Symp Quant Biol 54(Pt 1):445-451
46. Panina-Bordignon P, Tan A, Termijtelen A, Demotz S, Corradin G, Lanzavecchia A (1989b) Universally immunogenic T cell epitopes: promiscuous binding to human MHC class II and promiscuous recognition by T cells. Eur J Immunol 19(12):2237-2242
47. Peretti M, Villard J, Barras E, Zufferey M, Reith W (2001) Expression of the three human major histocompatibility complex class II isotypes exhibits a differential dependence on the transcription factor RFXAP. Mol Cell Biol 21(17):5699-5709
48. Robinson J, Malik A, Parham P, Bodmer JG, Marsh SG (2000) IMGT/HLA database-a sequence database for the human major histocompatibility complex. Tissue Antigens 55(3):280-287
49. Robinson J, Waller MJ, Parham P, de Groot N, Bontrop R, Kennedy LJ, Stoehr P, Marsh SG (2003) IMGT/HLA and IMGT/MHC: sequence databases for the study of the major histocompatibility complex. Nucleic Acids Res 31(1):311-314
50. Robinson J, Mistry K, McWilliam H, Lopez R, Parham P, Marsh SG (2011) The IMGT/HLA database. Nucleic Acids Res 39(Database issue):D1171-D1176. doi: 10.1093/nar/gkq998
51. Roche PA, Cresswell P (1990) High-affinity binding of an influenza hemagglutinin-derived peptide to purified HLA-DR. J Immunol 144(5):1849-1856
52. Sekaly RP, Jacobson S, Richert JR, Tonnelle C, McFarland HF, Long EO (1988) Antigen presentation to HLA class II-restricted measles virus-specific T-cell clones can occur in the absence of the invariant chain. Proc Natl Acad Sci U S A 85(4):1209-1212
53. Sidney J, Southwood S, Oseroff C, del Guercio MF, Sette A, Grey HM (2001) Measurement of MHC/peptide interactions by gel filtration. Curr Protoc Immunol Chapter 18:Unit 18 13. doi: 10.1002/0471142735.im1803s31
54. Sidney J, Assarsson E, Moore C, Ngo S, Pinilla C, Sette A, Peters B (2008) Quantitative peptide binding motifs for 19 human and mouse MHC class I molecules derived using positional scanning combinatorial peptide libraries. Immunome Res 4:2. doi: 10.1186/1745-7580-4-2
55. Sidney J, Steen A, Moore C, Ngo S, Chung J, Peters B, Sette A (2010a) Divergent motifs but overlapping binding repertoires of six HLA-DQ molecules frequently expressed in the worldwide human population. J Immunol 185(7):4189-4198. doi: 10.4049/jimmunol.1001006
56. Sidney J, Steen A, Moore C, Ngo S, Chung J, Peters B, Sette A (2010b) Five HLA-DP molecules frequently expressed in the worldwide human population share a common HLA supertypic binding specificity. J Immunol 184(5):2492-2503. doi: 10.4049/jimmunol.0903655
57. Sinigaglia F, Guttinger M, Kilgus J, Doran DM, Matile H, Etlinger H, Trzeciak A, Gillessen D, Pink JR (1988) A malaria T-cell epitope recognized in association with most mouse and human MHC class II molecules. Nature 336(6201):778-780
58. Solomon C, Southwood S, Hoof I, Rudersdorf R, Peters B, Sidney J, Pinilla C, Marcondes MC, Ling B, Marx P, Sette A, Mothe BR (2010) The most common Chinese rhesus macaque MHC class I molecule shares peptide binding repertoire with the HLA-B7 supertype. Immunogenetics 62(7):451-464. doi: 10.1007/s00251-010-0450-3
59. Southwood S, Sidney J, Kondo A, del Guercio MF, Appella E, Hoffman S, Kubo RT, Chesnut RW, Grey HM, Sette A (1998) Several common HLA-DR types share largely overlapping peptide binding repertoires. J Immunol 160(7):3363-3373
60. Tishkoff SA, Reed FA, Friedlaender FR, Ehret C, Ranciaro A, Froment A, Hirbo JB, Awomoyi AA, Bodo JM, Doumbo O, Ibrahim M, Juma AT, Kotze MJ, Lema G, Moore JH, Mortensen H, Nyambo TB, Omar SA, Powell K, Pretorius GS, Smith MW, Thera MA, Wambebe C, Weber JL, Williams SM (2009) The genetic structure and history of Africans and African Americans. Science 324(5930):1035-1044. doi: 10.1126/science.1172257
61. Vita R, Zarebski L, Greenbaum JA, Emami H, Hoof I, Salimi N, Damle R, Sette A, Peters B (2010) The immune epitope database 2.0. Nucleic Acids Res 38(Database issue):D854-D862. doi: 10.1093/nar/gkp1004
62. Wang RF (2009) Molecular cloning and characterization of MHC class I- and II-restricted tumor antigens recognized by T cells. In: Coligan JE, et al. (eds) Current protocols in immunology. doi: 10.1002/0471142735.im2010s84
63. Wang P, Sidney J, Dow C, Mothe B, Sette A, Peters B (2008) A systematic assessment of MHC class II peptide binding predictions and evaluation of a consensus approach. PLoS Comput Biol 4(4):e1000048. doi: 10.1371/journal.pcbi. 1000048
64. Wang P, Sidney J, Kim Y, Sette A, Lund O, Nielsen M, Peters B (2010) Peptide binding predictions for HLA DR, DP and DQ molecules. BMC Bioinforma 11:568. doi: 10.1186/1471-2105-11-568
65. Wilson CC, Palmer B, Southwood S, Sidney J, Higashimoto Y, Appella E, Chesnut R, Sette A, Livingston BD (2001) Identification and antigenicity of broadly cross-reactive and conserved human immunodeficiency virus type 1-derived helper T-lymphocyte epitopes. J Virol 75(9):4195-4207. doi: 10.1128/jvi.75.9.4195-4207.2001
66. Yang J, James EA, Huston L, Danke NA, Liu AW, Kwok WW (2006) Multiplex mapping of CD4 T cell epitopes using class II tetramers. Clin Immunol 120(1):21-32. doi: 10.1016/j.clim.2006.03.008